Authors: M. Gershenson, David, Miller, Austin, E Brady, William, Paul, James, Carty, Karen, Rodgers, William, Millan, David, L Coleman, Robert, N Moore, Kathleen, Banerjee, Susana, Connolly, Kate, Alvarez Secord, Angeles, M O'Malley, David, Dorigo, Oliver, Gaillard, Stephanie, Gabra, Hani, Slomovitz, Brian, Hanjani, Parviz, Farley, John, Churchman, Michael, Ewing, Ailith, Hollis, Robb, Herrington, C Simon, Q Huang, Helen, B Wenzel, Lari, Gourley, Charlie
Source: M. Gershenson, D, Miller, A, E Brady, W, Paul, J, Carty, K, Rodgers, W, Millan, D, L Coleman, R, N Moore, K, Banerjee, S, Connolly, K, Alvarez Secord, A, M O'Malley, D, Dorigo, O, Gaillard, S, Gabra, H, Slomovitz, B, Hanjani, P, Farley, J, Churchman, M, Ewing, A, Hollis, R, Herrington, C S, Q Huang, H, B Wenzel, L & Gourley, C 2022, ' Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): a randomised, open-label phase 2/3 trial ', The Lancet, vol. 399, no. 10324, pp. 541-553 . https://doi.org/10.1016/S0140-6736(21)02175-9
Subject Terms: Administration, Oral, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Carcinoma, Ovarian Epithelial/drug therapy, Female, Humans, MAP Kinase Kinase 1/metabolism, Middle Aged, Neoplasm Grading, Neoplasm Recurrence, Local/pathology, Ovarian Neoplasms/drug therapy, Paclitaxel/administration & dosage, Progression-Free Survival, Pyridones/administration & dosage, Pyrimidinones/administration & dosage, Standard of Care, Treatment Outcome, United Kingdom, United States
File Description: application/pdf
Access URL:
https://explore.openaire.eu/search/publication?articleId=od______3094::10daf3830e8817199b8469c4d2ece72c
https://www.pure.ed.ac.uk/ws/files/251776167/PIIS0140673621021759.pdf
Authors: Aikou Okamoto, Mark F. Brady, Peter Ansell, David Cella, Joo-Hyun Nam, Mark A. Morgan, Karina Dahl Steffensen, Theresa L. Werner, Gini F. Fleming, Katherine M. Bell-McGuinn, Sudipta Bhattacharya, Jesús García-Donas, Danielle Sullivan, Kathleen N. Moore, Noa Ben-Baruch, Paul DiSilvestro, Christine K. Ratajczak, Charles A. Leath, Michael Friedlander, Ana Oaknin, Shibani Nicum, Robert L. Coleman, N.G. Cloven, Elizabeth M. Swisher, Andrea R. Hagemann, Mika Mizuno, Michael A. Bookman, Ramey D. Littell, Minh H. Dinh, Sally Baron-Hay, Carol Aghajanian, Bruce A. Bach
Source: Coleman, R L, Fleming, G F, Brady, M F, Swisher, E M, Steffensen, K D, Friedlander, M, Okamoto, A, Moore, K N, Efrat Ben-Baruch, N, Werner, T L, Cloven, N G, Oaknin, A, DiSilvestro, P A, Morgan, M A, Nam, J-H, Leath, C A, Nicum, S, Hagemann, A R, Littell, R D, Cella, D, Baron-Hay, S, Garcia-Donas, J, Mizuno, M, Bell-McGuinn, K, Sullivan, D M, Bach, B A, Bhattacharya, S, Ratajczak, C K, Ansell, P J, Dinh, M H, Aghajanian, C & Bookman, M A 2019, ' Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer ', The New England Journal of Medicine, vol. 381, no. 25, pp. 2403-2415 . https://doi.org/10.1056/NEJMoa1909707
Subject Terms: General Medicine, Adenosine diphosphate, chemistry.chemical_compound, chemistry, Oncology, medicine.medical_specialty, medicine, business.industry, business, Clinical trial, Combined Modality Therapy, Veliparib, Progression-free survival, Internal medicine, Maintenance therapy, Ovarian cancer, medicine.disease, Chemotherapy, medicine.medical_treatment, Article, Administration, Oral, Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Benzimidazoles/adverse effects, Carboplatin/administration & dosage, Cystadenocarcinoma, Serous/drug therapy, Double-Blind Method, Female, Genes, BRCA1, Genes, BRCA2, Humans, Intention to Treat Analysis, Maintenance Chemotherapy, Middle Aged, Mutation, Ovarian Neoplasms/drug therapy, Paclitaxel/administration & dosage, Poly(ADP-ribose) Polymerase Inhibitors/adverse effects, Progression-Free Survival, Quality of Life
File Description: application/pdf
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fca7b04b7c61e036ac9e46850f4d7173
https://doi.org/10.1056/nejmoa1909707
Contributors: Instituto de Investigação e Inovação em Saúde
Source:
International Journal of Molecular Sciences, Vol 21, Iss 7768, p 7768 (2020)
International Journal of Molecular Sciences
Subject Terms: ovarian cancer, chemoresistance, drug repurposing, ex vivo cultures, lcsh:Biology (General), lcsh:QH301-705.5, lcsh:Chemistry, lcsh:QD1-999, Chemoresistance, Drug repurposing, Ex vivo cultures, Ovarian cancer, Diphosphonates / therapeutic use, Drug Repositioning / methods, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use, Itraconazole / therapeutic use, Ivermectin / therapeutic use, Metformin / therapeutic use, Neoplasm Recurrence, Local / prevention & control, Ovarian Neoplasms / drug therapy, Ovarian Neoplasms / pathology, Ritonavir / therapeutic use, Inorganic Chemistry, Organic Chemistry, Physical and Theoretical Chemistry, Computer Science Applications, Spectroscopy, Molecular Biology, General Medicine, Catalysis, Oncology, medicine.medical_specialty, medicine, Drug, media_common.quotation_subject, media_common, Efficacy, Itraconazole, medicine.drug, medicine.disease, Ritonavir, Internal medicine, Metformin, Bevacizumab, Drug repositioning, business.industry, business, Review
File Description: application/pdf
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ade72d4a51d3f46d9123c2a7191639d
https://www.mdpi.com/1422-0067/21/20/7768
Authors: Takeda, Gilberto Kendi, Leite, Daniela Batista, Junqueira, Michele Gilvana, Lopes, Luiz Augusto Freire, Silva, Ismael Dale Cotrim Guerreiro da, Baracat, Fausto Farah
Source: einstein (São Paulo). September 2011 9(3)
Subject Terms: Ovarian neoplasms/drug therapy, Polymorphism, genetic, Glutathione transferase
File Description: text/html
Accede al texto completo Authors: Hans Clevers, Kadi Lõhmussaar, Oded Kopper, Harry Begthel, Celien P.H. Vreuls, Jeroen Korving, Johan H. van Es
Contributors: Hubrecht Institute for Developmental Biology and Stem Cell Research
Source:
Nature Communications, 11(1). Nature Publishing Group
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
Nature Communications
Subject Terms: Animals, Antineoplastic Agents/pharmacology, BRCA1 Protein/genetics, CRISPR-Associated Protein 9, CRISPR-Cas Systems/genetics, Epithelium/pathology, Fallopian Tubes/pathology, Female, Gene Editing/methods, Mice, Mutation, Neurofibromatosis 1/genetics, Organ Culture Techniques/methods, Organoids/drug effects, Ovarian Neoplasms/drug therapy, Ovary/pathology, PTEN Phosphohydrolase/genetics, Tumor Suppressor Protein p53/genetics, endocrine system, Science, female genital diseases and pregnancy complications, endocrine system diseases, Article, Genetic engineering, Cancer models, Ovarian cancer, General Physics and Astronomy, General Biochemistry, Genetics and Molecular Biology, General Chemistry, Tumor progression, Organoid, Oviduct, Epithelium, medicine.anatomical_structure, medicine, PTEN, biology.protein, biology, Cancer, medicine.disease, Fallopian tube, Transplantation, Cancer research, lcsh:Science, lcsh:Q
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9a7f1303fbb141a1656f3962916050f
https://pure.knaw.nl/portal/en/publications/be147262-d4b8-425e-bb10-c36f7566d4f8
Authors: Mirza, Mansoor R, Monk, Bradley J, Herrstedt, Jørn, Oza, Amit M, Mahner, Sven, Redondo, Andrés, Fabbro, Michel, Ledermann, Jonathan A, Lorusso, Domenica, Vergote, Ignace, Ben-Baruch, Noa E, Marth, Christian, Madry, Radoslaw, Christensen, René D, Berek, Jonathan S, Dørum, Anne, Tinker, Anna V, du Bois, Andreas, González-Martín, Antonio, Follana, Philippe, Benigno, Benedict, Rosenberg, Per, Gilbert, Lucy, Rimel, Bobbie J, Buscema, Joseph, Balser, John P, Agarwal, Shefali, Matulonis, Ursula A, Lund, Bente, Malander, Susanne, Woie, Kathrine, Hellman, Kristina, Nøttrup, Trine Juhler, Havsteen, Hanne, Sehouli, Jalid, Harter, Philipp, Canzler, Ulrich, Lück, Hans-Joachim, Wölber, Linn, Marmé, Frederik, Meier, Werner, Heubner, Martin, Hilpert, Felix, Emons, Günter, Burges, Alexander, Bover Barcelo, Isabel Maria, Gil Martín, Marta, Palacio Vázquez, Isabel, Casado Herráez, Antonio, Maria del Campo, José, Lesoin, Anne, Berton-Rigaud, Dominique, N'Guyen, Thierry, Hardy-Bessard, Anne-Claire, Banerjee, Susana, Lord, Rosemary, Waters, Justin, Montes, Ana, Chan, Stephen, Williams, Sarah J, Barlow, Claire, Mullard, Anna, Colombo, Nicoletta, Scambia, Giovanni, Tognon, Germana, Scollo, Paolo, Kridelka, Frédéric, Leroy, Chantal, Debruyne, Philip, Huizing, Manon, Rosengarten, Ora, Levy, Talia, Frommer, Ronnie Shapira, Fishman, Ami, Edelman, David, Safra, Tamar, Amit, Amnon, Pikiel, Joanna, Suzin, Jacek, Mackowiak-Matejczyk, Beata, Reinthaller, Alexander, Petru, Edgar, Csoszi, Tibor, Bessette, Paul, Provencher, Diane, Lau, Susie, Ellard, Susan, Ghatage, Prafull, Moore, Kathleen, Wenham, Robert, Pineda, Mario, Azodi, Masoud, Mantia-Smaldone, Gina, Cloven, Noelle, Bailey, Cheryl, Lee, Christine, Secord, Angeles, Patel, Manish, Method, Michael, Callahan, Michael, Veena, John, Chan, John, Zarwan, Corrine, DiSilvestro, Paul, Teneriello, Michael, Gupta, Divya, Geller, Melissa, Burris, Howard, Slomovitz, Brian, Hendrickson, Andrea Wahner, McCormick, Colleen, Hanjani, Parviz, Blank, Stephanie, Haluska, Paul, Matei, Daniela, Vasilev, Stephen, Neidhart, Jeffrey, Boente, Matthew, Tchabo, Nana, Miller, David
Contributors: Targeted Gynaecologic Oncology (TARGON)
Source:
New England Journal of Medicine, 375(22), 2154-2164. MASSACHUSETTS MEDICAL SOC
Mirza, M R, Monk, B J, Herrstedt, J, Oza, A M, Mahner, S, Redondo, A, Fabbro, M, Ledermann, J A, Lorusso, D, Vergote, I, Ben-Baruch, N E, Marth, C, Mądry, R, Christensen, R D, Berek, J S, Dørum, A, Tinker, A V, du Bois, A, González-Martín, A, Follana, P, Benigno, B, Rosenberg, P, Gilbert, L, Rimel, B J, Buscema, J, Balser, J P, Agarwal, S, Matulonis, U A & ENGOT-OV16/NOVA Investigators 2016, ' Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer ', The New England Journal of Medicine, vol. 375, no. 22, pp. 2154-2164 . https://doi.org/10.1056/NEJMoa1611310
Subject Terms: General Medicine, Olaparib, chemistry.chemical_compound, chemistry, Internal medicine, medicine.medical_specialty, medicine, Recurrent Ovarian Cancer, Maintenance therapy, Rucaparib, Platinum sensitive, Oncology, Merck Sharp & Dohme, business.industry, business, Platinum compounds, Johnson Johnson, Obstetrics and Gynecology, NEGATIVE BREAST-CANCER, BRCA MUTATION CARRIERS, POLY(ADP-RIBOSE) POLYMERASE, SOLID TUMORS, OLAPARIB, TRIAL, Adolescent, Adult, Aged, Aged, 80 and over, Antineoplastic Agents/adverse effects, Bone Marrow/drug effects, Disease-Free Survival, Double-Blind Method, Female, Genes, BRCA1, Germ-Line Mutation, Homologous Recombination, Humans, Indazoles/adverse effects, Kaplan-Meier Estimate, Maintenance Chemotherapy, Middle Aged, Neoplasm Staging, Ovarian Neoplasms/drug therapy, Piperidines/adverse effects, Platinum Compounds/therapeutic use, Young Adult, Cancer and Oncology, Cancer och onkologi, Human health sciences, Reproductive medicine (gynecology, andrology, obstetrics), Sciences de la santé humaine, Médecine de la reproduction (Gynécologie, andrologie, obstétrique), Medizin
File Description: application/pdf
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ef1ddf8af7801e36d2502918a7877cf
https://doi.org/10.1056/nejmoa1611310
Authors: U. Kulsoom Abdul, Tse J. Wong, Andrea Weiss, Arjan W. Griffioen, Robert H. Berndsen, Patrick Meraldi, Patrycja Nowak-Sliwinska, Paul J. Dyson
Source:
Scientific Reports, Vol. 7 (2017) P. 43005
Scientific Reports
Subject Terms: Multidisciplinary, Pharmacology, Viability assay, Epidermal growth factor receptor, biology.protein, biology, Erlotinib, medicine.drug, medicine, Chorioallantoic membrane, Cell culture, Ovarian carcinoma, In vivo, Neovascularization, medicine.symptom, ddc:612, ddc:615, Animals, Antineoplastic Agents/chemistry/pharmacology/therapeutic use, Cell Line, Tumor, Cell Movement/drug effects, Cell Survival/drug effects, Cellular Senescence/drug effects, Chickens, Chorioallantoic Membrane/drug effects/physiology, Cymenes, Drug Resistance, Neoplasm/drug effects, Drug Synergism, Drug Therapy, Combination, Erlotinib Hydrochloride/chemistry/pharmacology/therapeutic use, Female, Human Umbilical Vein Endothelial Cells, Humans, Mice, Nude, Physiologic/drug effects, Organometallic Compounds/chemistry/pharmacology/therapeutic use, Ovarian Neoplasms/drug therapy/pathology, Article
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac5d21fab0344ee123f6302966dd24ba
https://doi.org/10.1038/srep43005
Source: Revista Brasileira de Oftalmologia, Volume: 74, Issue: 4, Pages: 254-256, Published: AUG 2015
Subject Terms: Quimioterapia/efeitos adversos, Paclitaxel/toxicidade, Edema macular/induzido quimicamente, Acuidade visual/efeitos de drogas, Neoplasias ovarianas/quimioterapia, Relatos de caso, Chemotherapy/adverse effects, Paclitaxel/toxicity, Macular edema/chemically induced, Visual acuity/drug effects, Ovarian neoplasms/drug therapy, Case reports, genetic structures, eye diseases, sense organs
File Description: text/html
Access URL:
https://explore.openaire.eu/search/publication?articleId=od_______608::4c840caa2db0a341bf7e4cd0d3dad9a2
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802015000400254&lng=en&tlng=en
Authors: H.J.G. Arts, Harmen Hollema, de Steven Jong, van der Ate Zee, K. A. ten Hoor, de Elisabeth G. E. Vries
Contributors: Targeted Gynaecologic Oncology (TARGON)
Source: Gynecologic Oncology, 92(3), 794-800. ACADEMIC PRESS INC ELSEVIER SCIENCE
Subject Terms: Obstetrics and Gynecology, Oncology, Tumor Necrosis Factor Decoy Receptors, Chemotherapy, medicine.medical_treatment, medicine, Immunohistochemistry, Receptor, Apoptosis, medicine.medical_specialty, Cancer cell, Ovarian tumor, Stromal cell, business.industry, business, Internal medicine, Apoptosis Regulatory Proteins, Female, GPI-Linked Proteins, Humans, Membrane Glycoproteins/biosynthesis, Neoplasm Staging, Ovarian Neoplasms/drug therapy, Paraffin Embedding, Receptors, TNF-Related Apoptosis-Inducing Ligand, Receptors, Tumor Necrosis Factor/biosynthesis, Receptors, Tumor Necrosis Factor, Member 10c, TNF-Related Apoptosis-Inducing Ligand, Tumor Necrosis Factor-alpha/biosynthesis, Receptors, Tumor Necrosis Factor/biosynthesis, Tumor Necrosis Factor, Member 10c
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53a2c78359d4e3ba978c6a2d1047ecf6
https://doi.org/10.1016/j.ygyno.2003.11.054
Authors: Dick J. Tinga, Elisabeth G.E. de Vries, Henriette J. G. Arts, Ate G.J. van der Zee, Pax H.B. Willemse
Contributors: Targeted Gynaecologic Oncology (TARGON)
Source: Gynecologic Oncology, 69(1), 32-35. ACADEMIC PRESS INC ELSEVIER SCIENCE
Subject Terms: Adult, Antineoplastic Agents, Phytogenic/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma/drug therapy, Catheterization/methods, Catheters, Indwelling, Cisplatin/administration & dosage, Cyclophosphamide/administration & dosage, Female, Humans, Infusions, Intravenous, Parenteral, Intraoperative Complications, Laparoscopy/methods, Middle Aged, Ovarian Neoplasms/drug therapy, Paclitaxel/administration & dosage, Tissue Adhesions, Antineoplastic Agents, Phytogenic/administration & dosage, Catheters, Indwelling, Infusions, Intravenous, Infusions, Parenteral, Obstetrics and Gynecology, Oncology, Ovarian carcinoma, Chemotherapy, medicine.medical_treatment, medicine, Cyclophosphamide, medicine.drug, Laparoscopic surgery, Veress needle, Catheter, business.industry, business, Insufflation, Surgery, medicine.medical_specialty, Laparotomy
Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6776cb8d8dcff5164b0816bc0f48fdc9
Authors: Petr Štěpnička, Yoshihisa Sei, Lucienne Juillerat-Jeanneret, Bruno Therrien, Mathieu Auzias, Georg Süss-Fink, Kentaro Yamaguchi, Frédéric Schmitt
Source: Journal of Biological Inorganic Chemistry, vol. 14, no. 5, pp. 693-701
Subject Terms: Antineoplastic Agents/chemical synthesis, Antineoplastic Agents/chemistry, Carcinoma/drug therapy, Cell Line, Tumor, Cell Survival/drug effects, Cells, Cultured, Electrochemistry, Female, Fibroblasts/cytology, Fibroblasts/drug effects, Humans, Molecular Structure, Organometallic Compounds/chemical synthesis, Organometallic Compounds/chemistry, Ovarian Neoplasms/drug therapy, Photosensitizing Agents/chemical synthesis, Photosensitizing Agents/chemistry, Porphyrins/chemical synthesis, Porphyrins/chemistry, Spectrum Analysis, Uterine Cervical Neoplasms/drug therapy, Inorganic Chemistry, Biochemistry, HeLa, biology.organism_classification, biology, Fluorescence, Stereochemistry, Photosensitizer, LNCaP, Cell culture, Porphyrin, chemistry.chemical_compound, chemistry, Cytotoxicity, Cancer, medicine.disease, medicine
File Description: application/pdf
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::094070ade7b16f4bcf793b5fceb1e46e
https://serval.unil.ch/notice/serval:BIB_238114A205C4
Authors: Albrecht Mannschreck, Richard Müller, Ulrich Klement, Thilo Spruß, Christoph Keller, Hans Dieter vom Orde, Ronald Gust, Klaus-Jürgen Range, Günther Bernhardt, Herta Reile, Helmut Schönenberger, Thomas Burgemeister
Source: Journal of Cancer Research and Clinical Oncology. 118:201-208
Subject Terms: Cancer Research, Oncology, General Medicine, Biochemistry, Phenols, chemistry.chemical_compound, chemistry, In vitro, Diamine, Stereoisomerism, Chemical synthesis, Cytotoxicity, Enantiomer, Ethylenediamine, Stereochemistry, 570 Biowissenschaften, Biologie, 540 Chemie, Adenocarcinoma/drug therapy, Antineoplastic Agents/chemical synthesis, Chromosome Aberrations, Female, Humans, Molecular Conformation, Organoplatinum Compounds/chemical synthesis, Ovarian Neoplasms/drug therapy, Tumor Cells, Cultured/drug effects, ddc:570, ddc:540
File Description: application/pdf
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75a877e81557cfe57dcc5b626ef83dba
https://doi.org/10.1007/bf01410135
Subject Terms: 570 Biowissenschaften, Biologie, ddc:570, 540 Chemie, ddc:540, Adenocarcinoma/drug therapy, Animals, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma/drug therapy, Cisplatin/administration & dosage, Drug Resistance, Drug Screening Assays, Antitumor, Female, Mammary Neoplasms, Animal/drug therapy, Methotrexate, Mice, Mice, Inbred Strains, Organ Size, Ovarian Neoplasms/drug therapy, Phosphorylcholine/administration & dosage, Tumor Cells, Cultured, Uterus/drug effects, Cancer Research, Oncology, General Medicine, Chemotherapy, medicine.medical_treatment, medicine, business.industry, business, Alkylphosphocholine, chemistry.chemical_compound, chemistry, Endocrinology, medicine.medical_specialty, Miltefosine, medicine.drug, Toxicity, Cisplatin, Combination therapy, Mechanism of action, medicine.symptom, Internal medicine, Adenocarcinoma, medicine.disease, Pharmacology
File Description: application/pdf
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6486a869785fbb94b98d5c3e18ac40c
https://epub.uni-regensburg.de/4844/
Source: Nature Communications vol.11 (2020) date: 2020-05-27 nr.1 p.2660 [ISSN 2041-1723]
Index Terms: Animals, Antineoplastic Agents/pharmacology, BRCA1 Protein/genetics, CRISPR-Associated Protein 9, CRISPR-Cas Systems/genetics, Epithelium/pathology, Fallopian Tubes/pathology, Female, Gene Editing/methods, Mice, Mutation, Neurofibromatosis 1/genetics, Organ Culture Techniques/methods, Organoids/drug effects, Ovarian Neoplasms/drug therapy, Ovary/pathology, PTEN Phosphohydrolase/genetics, Tumor Suppressor Protein p53/genetics, Artikel, Article
Source: Nature Communications vol.11 (2020) date: 2020-05-27 nr.1 p.2660 [ISSN 2041-1723]
Index Terms: Animals, Antineoplastic Agents/pharmacology, BRCA1 Protein/genetics, CRISPR-Associated Protein 9, CRISPR-Cas Systems/genetics, Epithelium/pathology, Fallopian Tubes/pathology, Female, Gene Editing/methods, Mice, Mutation, Neurofibromatosis 1/genetics, Organ Culture Techniques/methods, Organoids/drug effects, Ovarian Neoplasms/drug therapy, Ovary/pathology, PTEN Phosphohydrolase/genetics, Tumor Suppressor Protein p53/genetics, Artikel, Article
Source: Nature Medicine vol.25 (2019) nr.5 p.838-849 [ISSN 1078-8956]
Index Terms: Adult, Aged, Animals, Cell Line, Tumor, Drug Screening Assays, Antitumor, Female, Genomics, Heterografts, Humans, Mice, SCID, Middle Aged, Mutation, Organoids/pathology, Ovarian Neoplasms/drug therapy, Precision Medicine, Artikel, Article
Source: Mirza , M R , Bergmann , T K , Mau-Sørensen , M , Christensen , R D , Åvall-Lundqvist , E , Birrer , M J , Jørgensen , M , Roed , H , Malander , S , Nielsen , F , Lassen , U , Brøsen , K , Bjørge , L & Mäenpää , J 2019 , ' A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer : NSGO AVANOVA1/ENGOT-OV24 ' , Cancer Chemotherapy and Pharmacology , vol. 84 , no. 4 , pp. 791-798 .
Index Terms: Adult, Angiogenesis Inhibitors/administration & dosage, Antineoplastic Agents/administration & dosage, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab/administration & dosage, Carcinoma, Ovarian Epithelial/drug therapy, Dose-Response Relationship, Drug, Drug Monitoring/methods, Female, Humans, Indazoles/administration & dosage, Middle Aged, Ovarian Neoplasms/drug therapy, Piperidines/administration & dosage, Poly(ADP-ribose) Polymerase Inhibitors/administration & dosage, Progression-Free Survival, article
URL:
Source: Nature Medicine vol.25 (2019) nr.5 p.838-849 [ISSN 1078-8956]
Index Terms: Adult, Aged, Animals, Cell Line, Tumor, Drug Screening Assays, Antitumor, Female, Genomics, Heterografts, Humans, Mice, SCID, Middle Aged, Mutation, Organoids/pathology, Ovarian Neoplasms/drug therapy, Precision Medicine, Artikel, Article
Source: Dixon , S C , Nagle , C M , Wentzensen , N , Trabert , B , Beeghly-Fadiel , A , Schildkraut , J M , Moysich , K B , deFazio , A , Risch , H A , Rossing , M A , Doherty , J A , Wicklund , K G , Goodman , M T , Modugno , F , Ness , R B , Edwards , R P , Jensen , A , Kjær , S K , Høgdall , E , Berchuck , A , Cramer , D W , Terry , K L , Poole , E M , Bandera , E V , Paddock , L E , Anton-Culver , H , Ziogas , A , Menon , U , Gayther , S A , Ramus , S J , Gentry-Maharaj , A , Pearce , C L , Wu , A H , Pike , M C , Webb , P M & Australian Ovarian Cancer Study Group 2017 , ' Use of common analgesic medications and ovarian cancer survival : results from a pooled analysis in the Ovarian Cancer Association Consortium ' , B J C , vol. 116 , no. 9 , pp. 1223-1228 .
Index Terms: Acetaminophen/therapeutic use, Adult, Aged, Analgesics/therapeutic use, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Anticarcinogenic Agents/therapeutic use, Aspirin/therapeutic use, Disease-Free Survival, Female, Humans, Middle Aged, Ovarian Neoplasms/drug therapy, Proportional Hazards Models, Risk Factors, article
URL: